baseline_peak
TL2 Member · Valencia, ES
UK-based. Mostly the access and pricing categories.
Joined 15 August 2025 · last posted 1d · groups: regional-uk
77 posts, newest first. Showing up to 150.
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #61 · Evidence › Trials · 27 Jul 2026 · 10 likes post #60 is right about the mechanism and I think understates the practical bit. Confounding in observational data: a third variable can explain an apparent…
-
Submitting a sample: the process end to end Replied, post #109 · Sourcing › Independent verification · 25 Jul 2026 · 0 likes I read post #107 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Tracking a shortage from primary sources rather than rumour Replied, post #117 · Access › Shortages · 22 Jul 2026 · 14 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Review: an evidence digest and the citation check that delayed it Replied, post #17 · Documentation › Doc review · 21 Jul 2026 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here.…
-
Restarting after a long gap: what the labelling implies Replied, post #26 · Practice › Dosing & titration · 15 Jul 2026 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Impurity thresholds: where the common numbers come from Replied, post #5 · Analytics › Impurities & related substances · 14 Jul 2026 · 16 likes I read post #3 twice before replying, because I had assumed the opposite. Aggregates: multiples of the monomer mass. May not elute at all under a standard…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #23 · Access › Insurance & coverage · 13 Jul 2026 · 1 like post #22 answers the question as asked. The question underneath it is different. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance…
-
Coming back to: Time to steady state after a dose increase Replied, post #96 · Pharmacology › Pharmacokinetics · 8 Jul 2026 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #12 · Analytics › Home & field testing · 27 Jun 2026 · 5 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #85 · Devices › Syringes & needles · 26 Jun 2026 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #4 · Analytics › Home & field testing · 15 Jun 2026 · 21 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #26 · Access › Pricing · 1 Jun 2026 · 30 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
A 40-week log with the measurement method stated — what changed since Replied, post #5 · Outcomes › Progress reports · 23 May 2026 · 2 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Five questions in one post gets you one answer — how to split them Replied, post #88 · Start Here › How to Ask · 22 May 2026 · 0 likes On post #84 — agreed on the reasoning, with one qualification. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #30 · Compounds › Semaglutide · 17 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #10 · Research Methods › N-of-1 designs · 26 Apr 2026 · 0 likes Worth separating two things that post #6 runs together. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach.…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #92 · Practice › Interactions · 25 Apr 2026 · 33 likes post #91 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Comparing the STEP programme populations: who was actually enrolled Replied, post #2 · Compounds › Semaglutide · 24 Apr 2026 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #37 · Practice › Reconstitution · 20 Apr 2026 · 0 likes post #36 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
The "under review" status pill and when a moderator applies it Replied, post #70 · Evidence › Preprints · 13 Apr 2026 · 10 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #56 · Data & Tools › Calculators · 9 Apr 2026 · 0 likes Coming back to post #54, because the follow-up matters more than the original answer. Mass error checking: enter your observed mass and theoretical mass and check…
-
Spike-and-recover accuracy for a peptide assay Replied, post #53 · Analytics › Method validation · 8 Apr 2026 · 1 like Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #51 · Analytics › Mass spectrometry · 3 Apr 2026 · 0 likes Resolution: "high resolution" commonly means
-
The lowest dose that does anything: is that a real question? Replied, post #95 · Practice › Dosing & titration · 7 Mar 2026 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #32 · Data & Tools › Datasets · 1 Mar 2026 · 32 likes post #31 is right about the mechanism and I think understates the practical bit. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation,…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #3 · Analytics › Impurities & related substances · 19 Feb 2026 · 1 like Picking up post #2: that is the part I would want checked first. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double…
-
Coming back to: Training through a dose escalation week Replied, post #24 · Nutrition & Training › Resistance training · 7 Feb 2026 · 28 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
[2026 update] What a purity-only report leaves out Replied, post #11 · Sourcing › Independent verification · 29 Jan 2026 · 1 like Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #127 · Clinical › Special populations · 27 Jan 2026 · 10 likes post #126 is right about the mechanism and I think understates the practical bit. Adolescents: a distinct evidence base exists. The compounds are not approved for…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #24 · Clinical › Special populations · 26 Jan 2026 · 17 likes Worth separating two things that post #20 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #17 · Practice › Reconstitution · 26 Jan 2026 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reused chromatograms across lots: how to spot it Replied, post #15 · Analytics › COA interpretation · 21 Jan 2026 · 16 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #13 · Sourcing › Logistics · 27 Dec 2025 · 13 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Guidelines revision: what changed and why — one year on Replied, post #40 · Meta › Announcements · 27 Nov 2025 · 32 likes Picking up post #37: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #88 · Analytics › Home & field testing · 2 Nov 2025 · 21 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #69 · Start Here › Welcome · 19 Oct 2025 · 0 likes Coming back to post #67, because the follow-up matters more than the original answer. The compound and evidence pages are updated regularly and they are worth reading…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #30 · Data & Tools › Datasets · 8 Oct 2025 · 18 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Compounds this community declines to help with, and why Replied, post #33 · Compounds › Other compounds · 29 Sep 2025 · 26 likes This follows post #30 rather than contradicting it. Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #62 · Lounge › Off topic · 28 Sep 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #28 · Evidence › Study critique · 13 Sep 2025 · 6 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #18 · Compounds › Tirzepatide · 12 Sep 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
When a preprint is the best available evidence and we say so Replied, post #157 · Evidence › Preprints · 8 Sep 2025 · 3 likes post #156 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Getting a referral rather than a refusal Started this topic · Clinical › Prescriber conversations · 3 Sep 2025 · 42 likes Getting a referral rather than a refusal — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #105 · Practice › Reconstitution · 13 Aug 2025 · 5 likes Picking up post #102: that is the part I would want checked first. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? Replied, post #2 · marked as the solution · Clinical › Special populations · 7 Aug 2025 · 22 likes Coming back to the opening post, because the follow-up matters more than the original answer. Adolescents: a distinct evidence base exists. The compounds are not…
-
Follow-up: Sodium, potassium and magnesium when intake drops Started this topic · Nutrition & Training › Hydration & electrolytes · 22 Jul 2025 · 35 likes On the subject in the title: Sodium, potassium and magnesium when intake drops Working notes rather than a conclusion. Longitudinal report with the method stated,…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #69 · Compounds › Repair & healing peptides · 12 Jul 2025 · 20 likes post #68 is right about the mechanism and I think understates the practical bit. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Dose numbers across compounds are not on the same scale Started this topic · Practice › Dosing & titration · 7 Jul 2025 · 0 likes Dose numbers across compounds are not on the same scale — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this…
-
Insulin combinations and hypoglycaemia risk Replied, post #7 · Practice › Interactions · 13 Jun 2025 · 28 likes post #6 is right about the mechanism and I think understates the practical bit. Food interactions: most interactions are absorption interactions. Some medications…
-
Coming back to: Getting a referral rather than a refusal Replied, post #62 · Clinical › Prescriber conversations · 12 Jun 2025 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #56 · Nutrition & Training › Protein & intake · 10 Jun 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] US compounding rules and how they changed Replied, post #17 · Regional › North America · 5 Jun 2025 · 2 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #21 · Access › Pricing · 22 May 2025 · 0 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #3 · Clinical › Bloodwork · 21 May 2025 · 8 likes Picking up post #2: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #25 · Evidence › Trials · 14 May 2025 · 0 likes post #24 is right about the mechanism and I think understates the practical bit. Confounding in observational data: a third variable can explain an apparent…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #61 · Evidence › Journal club · 24 Apr 2025 · 0 likes On post #57 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 11 Apr 2025 · 5 likes This follows post #26 rather than contradicting it. For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and…
-
Carryover and the ghost peak from last week's standard Replied, post #60 · Analytics › HPLC & UHPLC · 8 Apr 2025 · 0 likes post #59 is right about the mechanism and I think understates the practical bit. Area percent is not mass percent. It is a proportion of absorbance, weighted by each…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #8 · Evidence › Journal club · 28 Mar 2025 · 10 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #28 · Clinical › Comorbidities · 7 Mar 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #10 · Start Here › Welcome · 26 Feb 2025 · 25 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
An orphaned page with no inbound links Replied, post #10 · Meta › Wiki maintenance · 19 Feb 2025 · 7 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
-
When "no data" is the complete and final answer Replied, post #94 · Compounds › Other compounds · 16 Feb 2025 · 5 likes Picking up post #91: that is the part I would want checked first. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent…
-
Body image changing more slowly than the body Replied, post #108 · Wellbeing › Mental health · 23 Dec 2024 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Fixed versus detachable needles: the trade-offs Replied, post #43 · Devices › Syringes & needles · 10 Dec 2024 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #43 · Nutrition & Training › Protein & intake · 7 Dec 2024 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #21 · Wellbeing › Mental health · 27 Nov 2024 · 9 likes post #20 answers the question as asked. The question underneath it is different. Identity and self-image: for some people, weight and body size are central to identity.…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #13 · Devices › Cold chain · 23 Nov 2024 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #3 · Sourcing › Vendor reports · 2 Nov 2024 · 0 likes This follows post #2 rather than contradicting it. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water,…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #35 · Compounds › Tirzepatide · 16 Oct 2024 · 30 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #9 · Analytics › Impurities & related substances · 16 Oct 2024 · 6 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #121 · Access › Shortages · 13 Oct 2024 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #100 · Clinical › Bloodwork · 11 Oct 2024 · 8 likes Coming back to post #98, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #54 · Access › Shortages · 11 Oct 2024 · 6 likes Coming back to post #52, because the follow-up matters more than the original answer. Supply interruptions: official shortage notices are published by regulatory…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #10 · Compounds › Oral incretins · 27 Aug 2024 · 0 likes Coming back to post #8, because the follow-up matters more than the original answer. Why an oral formulation is a formulation achievement: the molecule is the same but…
-
Circumference measurements as a poor man's composition estimate Replied, post #75 · Outcomes › Body composition · 17 Aug 2024 · 0 likes On post #71 — agreed on the reasoning, with one qualification. Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #16 · Practice › Interactions · 8 Jul 2024 · 1 like This follows post #13 rather than contradicting it. Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others…